SC
Basic Science

Thursday, June 2, 2016: 6:15 PM-8:15 PM
Exhibit Hall
Blocking the Lipid Metabolism As a New Treatment Strategy for Multiple Sclerosis
Anne S. Mĝrkholt, PhD Student, Aalborg University; Soeren Nielsen, MD. Prof., Aalborg University; John D Nieland, PhD. Assoc. Prof., Aalborg University
PDF
Effects of Disability on Lower Extremity Joint Contributions and Total Support Moment in Individuals with Multiple Sclerosis
Brandi Decoux, M.S., Auburn University; Lauren Brewer, M.Ed., Auburn University; Emily Riser, MD, Tanner Center and Foundation for Multiple Sclerosis; Wei Liu, Ph.D., Auburn University

T- and B-Lymphocyte Modulation Associated with Teriflunomide Treatment in Patients with Relapsing-Remitting MS: Analysis of the Phase 3b TERI-DYNAMIC Study
Heinz Wiendl, MD, University of Münster; Catharina C Gross, PhD, University of Münster; Maren Lindner, PhD, University of Münster; Melanie Eschborn, MSc, University of Münster; Linda Weisser, PhD, University of Münster; Anita Posevitz-Fejfar, PhD, University of Münster; Andreas Schulte-Mecklenbeck, PhD, University of Münster; Bart Van Wijmeersch, MD, PhD, Hasselt University, Campus Diepenbeek; Sandrine Brette, MSc, Lincoln; Timothy J Turner, PhD, Genzyme, a Sanofi company; Alexandre Jagerschmidt, PhD, Sanofi R&D; Amit Bar-Or, MD, FRCPC, Montreal Neurological Institute; Raymond Hupperts, MD, PhD, School for Mental Health and Neuroscience, Maastricht University; Luisa Klotz, MD, University of Münster
PDF
Modeling Neural Progenitor Cell Dysfunction and Neurogenesis in a Stem Cell-Based Assay Model of Multiple Sclerosis
Jaime Imitola, MD, Ohio State University; Michael K Racke, MD, The Ohio State University Wexner Medical Center; Fumihiro Watanabe, MD PhD, Ohio State University

Microbial Sequences in Multiple Sclerosis Brain Specimens
John D Kriesel, MD, University of Utah School of Medicine; Preetida J Bhetariya, Ph.D., University of Utah; Cheryl Palmer, MD, University of Utah School of Medicine; Kael F Fischer, Ph.D., University of Utah School of Medicine; Alun Thomas, Ph.D., University of Utah School of Medicine

Dimethyl Fumarate Associated Lymphopenia Appears Driven by Selective CD8+ T Cell Depletion
Jong-Mi Lee, MSN - NP, Stanford Healthcare; Jeffrey Dunn, MD, Stanford University Medical Center; Jong-Mi Lee, MSN - NP, Stanford Healthcare

Novel Biomarker of Balance Impairment in Minimally Impaired Individuals with MS
Kathleen L Roeing, BS, University of Illinois at Urbana-Champaign; Douglas A Wajda, MS, University of Illinois at Urbana-Champaign; Jacob J Sosnoff, PhD, University of Illinois at Urbana-Champaign

Assessing the Role of Citrullination and Lipid Interaction with Myelin Basic Protein in Multiple Sclerosis Etiology
Kenneth Kastaniegaard, MS, Aalborg University; Tue B Bennike, PhD, Aalborg University; Soeren Nielsen, MD. Prof., Aalborg University; Allan Stensballe, PhD. Assoc. Prof., Aalborg University; John D Nieland, PhD. Assoc. Prof., Aalborg University; Kenneth Kastaniegaard, MS, Aalborg University

Changes in JC (John Cunningham) Virus Antibody Index in JC Positive Multiple Sclerosis (MS) Patients Treated with Natalizumab
Malcolm H Gottesman, MD, Winthrop University Hosptial; Britany Klenofsky, MD, Mt. Sinai Beth Isreal; Stephen Newman, MD, Island Neurological Associates; Misu Paul, MD, Winthrop University Hosptial; Rose Calixite, PhD, Winthrop University Hosptial; Tiffany M Harding, CCRC, MSCS, Island Neurological Associates; Denise Grueneberg, RN, Winthrop University Hosptial
PDF
Effect of ACTH1-39 on the Oligodendroglial Differentiation Pathway with Regards to Myelin Membrane Sheet Formation
Andrew Kuo, M.S.E., Wayne State University School of Medicine; Robert P. Lisak, M.D., Wayne State University School of Medicine; Liljana Nedelkoska, B.S., Wayne State University School of Medicine; Beverly Bealmear, B.A., Wayne State University School of Medicine; Joyce A Benjamins, Ph.D., Wayne State University School of Medicine


See more of: CMSC